Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SS-Cream evaluated in subjects with premature ejaculation

Oct. 6, 1997

Regeneron and P&G joint development program for obesity

Oct. 3, 1997

L-Arginine not associated with objective improvement in organic ED

Oct. 3, 1997

Linsidomine + moxisylyte for ED

Oct. 3, 1997

Effects of BQ-123 and BQ-788 on ET-1-induced corpus cavernosum contractions

Oct. 3, 1997

Intracavernous moxisylyte recommended for first-line treatment of ED

Oct. 3, 1997

BioTime completes phase III trial with blood volume plasma extender

Oct. 3, 1997

First registration filing for Unigene's injectable calcitonin product

Oct. 2, 1997

Quinacrine sterilization reviewed

Oct. 2, 1997

New agents for NIDDM presented by Pharmacia & Upjohn

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...